Venmax Drugs & Pharmaceuticals Ltd

BSE :531015 NSE :- Sector : Pharmac..
25.28
Change: -0.51(-1.98%)
No Graph Available
52 week Low
6.27
52 week High
30.88
Day low
25.28
Day high
25.28
Prev Close
25.79
Open
25.28
6M return
284.19%
1Y return
284.19%
MCap(Rs. in Cr.)
13.25
Total Volume
20
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available

( in Cr.)
CompnameDCM Shriram Inds
Total Amt67,591.50
Gains-32.41
2023
2024 2025
2026


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Venmax Drugs
25.28
Change: -0.51 (-1.98%)
1 Year return
284.19%
Risk (Std Dev)
0.00%
PE Ratio
NM
MCap( in Cr.)
13.25
Shukra Pharma.
205.60
Change: 3.05 (1.51%)
1 Year return
319.08%
Risk (Std Dev)
0.48%
PE Ratio
109.95
MCap( in Cr.)
900.28
Oxygenta Pharma
82.56
Change: -1.68 (-1.99%)
1 Year return
159.46%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
305.34
Everest Organics
243.65
Change: -12.80 (-4.99%)
1 Year return
78.89%
Risk (Std Dev)
0.35%
PE Ratio
NM
MCap( in Cr.)
249.03
Pharmaids Pharma
61.94
Change: 0.00 (0.00%)
1 Year return
19.83%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
218.45
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 67,591.50 with a Loss of -32.41%

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

2023
2024
2025

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

View More

News

Stay tuned to the latest developments and happenings in the company.

Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the December 2024 quarter

Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during ....

08 Feb 2025 17:32

Venmax Drugs & Pharmaceuticals announces board meeting date

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 February 2025.Powered by Capital Market ....

04 Feb 2025 16:35

Venmax Drugs & Pharmaceuticals to conduct EGM

Venmax Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 February 2025.Powered ....

13 Jan 2025 11:36

Venmax Drugs & Pharmaceuticals announces board meeting date

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 January 2025.Powered by Capital Market ....

07 Jan 2025 10:08

Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.30 crore in the September 2024 quarter

Net Loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.30 crore in the quarter ended September 2024 as against net loss of Rs 0.03 crore during t....

11 Nov 2024 16:52

Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter

Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended June 2024 as against Rs 0.02 crore during the previ....

13 Aug 2024 12:29

View More
Subscribe for our
newsletter
Open Account Now